Robert Blazej
InvestorPartner at Mission Biocapital · Board director at Telo Therapeutics, Inc.
San Francisco
Writes $500K checks
About
Robert Blazej, a UCSF/UC Berkeley bioengineer PhD who co‑founded Allopartis and led its Novozymes integration, has daily exposure to early scientific founders through dual partner/director roles in a life‑science incubator.
Contact· self-published, not guessed
Invests in
AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials
Board director at Telo Therapeutics, Inc.
Intro paths
→
In turn, Robert can intro founders to Telo Therapeutics, Inc.'s investors below.
Telo Therapeutics, Inc.'s investors · 1
Co-founders at Telo Therapeutics, Inc.
RB
Rob BellFounder
Experience
- ALLIn BioBoard Membercurrent2024 — presentSan Francisco Bay Area
- Nitrase TherapeuticsBoard Observercurrent2024 — presentSan Francisco Bay Area
- Interdict BioBoard Observercurrent2022 — presentSan Francisco Bay Area
- Telo Therapeutics, Inc.Board Membercurrent2021 — presentSan Francisco Bay Area
- Dren Bio, Inc.Board Observercurrent2020 — presentSan Francisco Bay Area
- MBC BiolabsVice President of Alliancescurrent2017 — present
- Mission Bay CapitalPartnercurrent2017 — presentSan Francisco CA
- Mission BioCapitalPartnercurrent2017 — presentCambridge MA
- GraphWear Technologies Inc.Board Member2024 — 2025San Francisco Bay Area
- Photoswitch Biosciences, Inc.Board Member2018 — 2023
- NovozymesManager2013 — 2017San Francisco Bay Area
- Allopartis Biotechnologies, Inc.CEO & President2007 — 2013San Francisco Bay Area
Skills & more
Biotechnology13Molecular Biology10Life Sciences4Biochemistry8PCR3Assay Development3Science5R&D1Venture Capital2Protein Chemistry5Lifesciences6Microfluidics2
+7 more
Biomedical EngineeringProject ManagementGenomicsMicrofabricationCell CulturePolymerase Chain Reaction (PCR)Research and Development (R&D)From Robert's professional profile.
Deals · 1
Telo Therapeutics, Inc.Board seat
via Mission Biocapital · filed Jun 2022 · $10.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Helen Siaw
Analyst at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Frequently asked questions
- Who is Robert Blazej?
- Robert Blazej, a UCSF/UC Berkeley bioengineer PhD who co‑founded Allopartis and led its Novozymes integration, has daily exposure to early scientific founders through dual partner/director roles in a life‑science incubator.
- Where does Robert Blazej work?
- Robert Blazej is Partner at Mission Biocapital and Board director at Telo Therapeutics, Inc..
- What does Robert Blazej invest in?
- Robert Blazej invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
- What check size does Robert Blazej write?
- Robert Blazej typically writes checks of $500K.
- What boards does Robert Blazej sit on?
- Robert Blazej holds tracked board seats at Telo Therapeutics, Inc..
- Where did Robert Blazej go to school?
- Robert Blazej studied at University of California, Berkeley (Doctor of Philosophy (Ph.D.), Bioengineering).
Same school
Also attended University of California, Berkeley1,453
Byron DeeterPartner at Bessemer Venture PartnersSteve WozniakCo-founder of AppleTony XuCo-founder & CEO of DoorDashAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksRyan PetersenFounder & CEO of Flexport
+ 1,447 more
